Application of exosomes as liquid biopsy in clinical diagnosis.
Biting ZhouKailun XuXi ZhengTing ChenJian WangYongmao SongYingkuan ShaoShu ZhengPublished in: Signal transduction and targeted therapy (2020)
Liquid biopsy refers to the sampling and molecular analysis of the biofluids of circulating tumor cells, extracellular vesicles, nucleic acids, and so forth. Exosomes are small extracellular vesicles with sizes between 30-150 nm. They are secreted by multivesicular bodies through exocytosis in live cells and can participate in intercellular communication due to their contents, including nucleic acids, proteins, and lipids. Herein, we investigate publication frequencies on exosomes over the past 10 years, and review recent clinical studies on liquid biopsy of exosomes in the fields of oncology, pregnancy disorders, cardiovascular diseases, and organ transplantation. We also describe the advantages of exosomes as an effective liquid biopsy tool and the progression of exosome extraction methods. Finally, we depict the commercial development of exosome research and discuss the future role of exosomes in liquid biopsy.
Keyphrases
- mesenchymal stem cells
- stem cells
- ultrasound guided
- fine needle aspiration
- circulating tumor cells
- ionic liquid
- cardiovascular disease
- induced apoptosis
- cell therapy
- bone marrow
- preterm birth
- cell proliferation
- cell death
- cell cycle arrest
- endoplasmic reticulum stress
- cardiovascular events
- cardiovascular risk factors
- cell adhesion